We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Small Molecule Drug, ONC201, Kills Breast Cancer Cells by Targeting Mitochondria

News   May 09, 2018 | Original story from Oncotarget

 
Small Molecule Drug, ONC201, Kills Breast Cancer Cells by Targeting Mitochondria

Breast Cancer Cells. Credit: National Cancer Institute \ Dana-Farber Harvard Cancer Center at Massachusetts General Hospital

 
 
Advertisement
 

RELATED ARTICLES

The Motivated Mind: Neuroimaging Shows What Effort Looks Like in the Brain

News

Scientists have discovered that the ventral striatum is activated during the decision-making of a physical effort.

READ MORE

Genetically Engineered T Cells a Possible Therapy for Autoimmune Diseases

News

A genetically engineered T cell has been found to effectively target and attack pathogenic cells that cause type one diabetes.

READ MORE

Novel Role of Immune System in Psoriasis

News

Scientists have uncovered another one of the complex immune-mediated mechanisms behind the onset of psoriasis and severe psoriasis lesions. The work highlights potential therapeutic targets for future treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Cell Science Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE